However, this was not as prominent in the MCF-7 and HEK293 cell lines, which suggests that the efficiency of His-containing NPs can be cell type-specific and warrants further investigation into their use for the possible treatment of HER2-overexpressing cancers. The gene discussed is ERBB2; the disease is cancer.